Yasuhisa Murai creator_r433ms2hnffcrkzysbwi7p3azy

Given name Yasuhisa
Surname Murai

Releases

This creator has contributed to:

2020-10-21 Cyclosporine protects from intestinal epithelial injury by modulating butyrate uptake via upregulation of membrane monocarboxylate transporter 1 levels
published | article-journal | CC-BY-NC-ND
doi:10.1016/j.bbrep.2020.100811
2021-02-03 SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors
published | article-journal | CC-BY-NC-ND
doi:10.1073/pnas.2015654118
2021-04-16 SLFN11 inactivation induces proteotoxic stress and sensitizes cancer cells to ubiquitin activating enzyme inhibitor TAK-243
published | article-journal
doi:10.1158/0008-5472.can-20-2694
2022-01-11 Endoscopic and histopathologic features of Anti‐PD‐1‐related collagenous colitis
published | article-journal | CC-BY
doi:10.1002/deo2.92
2022-04-19 TOP1-DNA trapping by exatecan and combination therapy with ATR inhibitor
published | article-journal
doi:10.1158/1535-7163.mct-21-1000
2022-06-10 Automated evaluation of colon capsule endoscopic severity of ulcerative colitis using ResNet50
published | article-journal
doi:10.1371/journal.pone.0269728
2021-05-27 Novel and highly potent ATR inhibitor M4344 kills cancer cells with replication stress and enhances the chemotherapeutic activity of widely used DNA damaging agents
published | article-journal
doi:10.1158/1535-7163.mct-20-1026
2023-07-25 ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer
published | article-journal
doi:10.15252/emmm.202217313
2023-08-01 Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication
published | article-journal
doi:10.1158/1535-7163.mct-22-0552
2021-09-14 Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11
published | article-journal | CC-BY
doi:10.3390/cancers13184601
2023-12-03 A Logistic Regression Model for Predicting the Risk of Subsequent Surgery among Patients with Newly Diagnosed Crohn's Disease Using a Brute Force Method
published | article-journal | CC-BY
doi:10.3390/diagnostics13233587
2024-02-16 Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer
published | unknown type
doi:10.1038/s44321-024-00029-x
2023-03-31 Data from SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243
unknown status | post | CC-BY
doi:10.1158/0008-5472.c.6513573.v1
2023-03-31 Data from SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243
unknown status | post | CC-BY
doi:10.1158/0008-5472.c.6513573
2023-02-08 Evaluation of Crohn's Disease Small-Bowel Mucosal Healing Using Capsule Endoscopy and Usefulness of Leucine-Rich α2-Glycoprotein
published | article-journal
doi:10.3390/diagnostics13040626
Lookup Links
wikidata.org
VIAF
dblp (CS)
Google Scholar
Catalog Record
Revision: 1703c63d-fe31-4f6b-95d1-0dec0a45cf7b
API URL: JSON